BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9862688)

  • 1. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.
    Annenkov AE; Moyes SP; Eshhar Z; Mageed RA; Chernajovsky Y
    J Immunol; 1998 Dec; 161(12):6604-13. PubMed ID: 9862688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta.
    Annenkov A; Chernajovsky Y
    Gene Ther; 2000 Apr; 7(8):714-22. PubMed ID: 10800096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
    Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
    Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes.
    Lustgarten J; Eshhar Z
    Eur J Immunol; 1995 Oct; 25(10):2985-91. PubMed ID: 7589102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chain.
    Shores E; Flamand V; Tran T; Grinberg A; Kinet JP; Love PE
    J Immunol; 1997 Jul; 159(1):222-30. PubMed ID: 9200458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional assembly of chimeric T-cell receptor chains.
    Gorochov G; Lustgarten J; Waks T; Gross G; Eshhar Z
    Int J Cancer Suppl; 1992; 7():53-7. PubMed ID: 1428405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
    Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
    J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
    Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
    Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of unique antibodies directed against each of the six different phosphotyrosine residues within the T cell receptor CD3ζ chain.
    Gelkop S; Weisman B; Pulak RN; Zharhary D; Isakov N
    J Immunol Methods; 2012 Jan; 375(1-2):129-37. PubMed ID: 22020291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
    Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the gamma-chain from Fc(epsilon) RI.
    Mamalaki A; Gritzapis AD; Kretsovali A; Belimezi M; Papamatheakis J; Perez SA; Papamichail M; Baxevanis CN
    Cancer Immunol Immunother; 2003 Aug; 52(8):513-22. PubMed ID: 12715240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD16-expressing CD8alpha alpha+ T lymphocytes in the intestinal epithelium: possible precursors of Fc gammaR-CD8alpha alpha+ T cells.
    She J; Simpson SJ; Gupta A; Holländer G; Levelt C; Liu CP; Allen D; van Houten N; Wang B; Terhorst C
    J Immunol; 1997 May; 158(10):4678-87. PubMed ID: 9144480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.
    Hombach A; Heuser C; Sircar R; Tillmann T; Diehl V; Pohl C; Abken H
    Cancer Res; 1998 Mar; 58(6):1116-9. PubMed ID: 9515791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.
    Mezzanzanica D; Canevari S; Mazzoni A; Figini M; Colnaghi MI; Waks T; Schindler DG; Eshhar Z
    Cancer Gene Ther; 1998; 5(6):401-7. PubMed ID: 9917095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chains.
    Hombach A; Sircar R; Heuser C; Tillmann T; Diehl V; Kruis W; Pohl C; Abken H
    Int J Mol Med; 1998 Jul; 2(1):99-103. PubMed ID: 9854151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.